Wei Y - Search Results

1

N6-methyladenosine modification promotes hepatocarcinogenesis through circ-CDYL-enriched and EpCAM-positive liver tumor-initiating exosomes.

Wei Y, Fu J, Zhang H, Ling Y, Tang X, Liu S, Yu M, Liu F, Zhuang G, Qian H, Zhang K, Yang P, Yang X, Yang Q, Ge S, Zhang B, Tan Y, Li L, Wang H. Wei Y, et al. iScience. 2023 Oct 13;26(10):108022. doi: 10.1016/j.isci.2023.108022. eCollection 2023 Oct 20. iScience. 2023. PMID: 37954137 Free PMC article.

2

A Noncoding Regulatory RNAs Network Driven by Circ-CDYL Acts Specifically in the Early Stages Hepatocellular Carcinoma.

Wei Y, Chen X, Liang C, Ling Y, Yang X, Ye X, Zhang H, Yang P, Cui X, Ren Y, Xin X, Li H, Wang R, Wang W, Jiang F, Liu S, Ding J, Zhang B, Li L, Wang H. Wei Y, et al. Hepatology. 2020 Jan;71(1):130-147. doi: 10.1002/hep.30795. Epub 2019 Aug 11. Hepatology. 2020. PMID: 31148183

3

MiR-552-3p promotes malignant progression of gallbladder carcinoma by reactivating the Akt/β-catenin signaling pathway due to inhibition of the tumor suppressor gene RGMA.

Song F, Yang Z, Li L, Wei Y, Tang X, Liu S, Yu M, Chen J, Wang S, Fu J, Zhang K, Yang P, Yang X, Chen Z, Zhang B, Wang H. Song F, et al. Among authors: wei y. Ann Transl Med. 2021 Sep;9(17):1374. doi: 10.21037/atm-21-2013. Ann Transl Med. 2021. PMID: 34733926 Free PMC article.

4

An RNA-RNA crosstalk network involving HMGB1 and RICTOR facilitates hepatocellular carcinoma tumorigenesis by promoting glutamine metabolism and impedes immunotherapy by PD-L1+ exosomes activity.

Wei Y, Tang X, Ren Y, Yang Y, Song F, Fu J, Liu S, Yu M, Chen J, Wang S, Zhang K, Tan Y, Han Z, Wei L, Zhang B, Cheng Z, Li L, Wang H. Wei Y, et al. Among authors: wei l. Signal Transduct Target Ther. 2021 Dec 17;6(1):421. doi: 10.1038/s41392-021-00801-2. Signal Transduct Target Ther. 2021. PMID: 34916485 Free PMC article.

5

Dual regulation of HMGB1 by combined JNK1/2-ATF2 axis with miR-200 family in nonalcoholic steatohepatitis in mice.

Chen X, Ling Y, Wei Y, Tang J, Ren Y, Zhang B, Jiang F, Li H, Wang R, Wen W, Lv G, Wu M, Chen L, Li L, Wang H. Chen X, et al. Among authors: wei y. FASEB J. 2018 May;32(5):2722-2734. doi: 10.1096/fj.201700875R. Epub 2018 Jan 3. FASEB J. 2018. PMID: 29298863

Our findings reveal a novel mechanism by which HMGB1 expression was regulated by both the JNK1/2-ATF2 axis and the miR-200 family, which provides a potential new approach for the treatment of NAFLD.-Chen, X., Ling, Y., Wei, Y., Tang, J., Ren, Y., Zhang …

Our findings reveal a novel mechanism by which HMGB1 expression was regulated by both the JNK1/2-ATF2 axis and the miR-200 family, which pro …

6

Development and validation of prognostic dynamic nomograms for hepatitis B Virus-related hepatocellular carcinoma with microvascular invasion after curative resection.

Bai S, Yang P, Wei Y, Wang J, Lu C, Xia Y, Si A, Zhang B, Shen F, Tan Y, Wang K. Bai S, et al. Among authors: wei y. Front Oncol. 2023 Apr 19;13:1166327. doi: 10.3389/fonc.2023.1166327. eCollection 2023. Front Oncol. 2023. PMID: 37152055 Free PMC article.

7

The construction of the novel magnetic prodrug Fe₃O₄@DOX and its antagonistic effects on hepatocarcinoma with low toxicity.

Li J, Li L, Lv Y, Zou H, Wei Y, Nie F, Duan W, Sedike M, Xiao L, Wang M. Li J, et al. Among authors: wei y. RSC Adv. 2020 Aug 5;10(48):28965-28974. doi: 10.1039/d0ra01729a. eCollection 2020 Aug 3. RSC Adv. 2020. PMID: 35520056 Free PMC article.

8

HtrA3 paves the way for MSC migration and promotes osteogenesis.

Guo Y, Ma S, Wang D, Mei F, Guo Y, Heng BC, Zhang S, Huang Y, Wei Y, He Y, Liu W, Xu M, Zhang X, Chen L, Deng X. Guo Y, et al. Among authors: wei y. Bioact Mater. 2024 May 11;38:399-410. doi: 10.1016/j.bioactmat.2024.05.016. eCollection 2024 Aug. Bioact Mater. 2024. PMID: 38774457 Free PMC article.

9

Effect of novel anti-tumor and anti-angiogenesis drug taurolactone on angiogenic factor AGGF1 and angiogenesis mimicry in patients with hepatocellular carcinoma.

Liu S, Wei Y, Nie L, Tang Z, Lu Q, Liang Q. Liu S, et al. Among authors: wei y. BMC Cancer. 2024 May 21;24(1):614. doi: 10.1186/s12885-024-12356-w. BMC Cancer. 2024. PMID: 38773427

10

Correction: O-GlcNAcylation of melanophilin enhances radiation resistance in glioblastoma via suppressing TRIM21 mediated ubiquitination.

Xu L, Ye Y, Tao Z, Wang T, Wei Y, Cai W, Wan X, Zhao P, Gu W, Gu B, Zhang L, Tian Y, Liu N, Tu Y, Ji J. Xu L, et al. Among authors: wei y. Oncogene. 2024 May 21. doi: 10.1038/s41388-024-03045-w. Online ahead of print. Oncogene. 2024. PMID: 38773264 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22,678 results

Search Page